Papers - Kinoshita, Shotaro

The Diffusion and Challenges of Telemedicine in the With/After COVID-19 Era

Shotaro Kinoshita

Journal of information and communications policy (総務省情報通信政策研究所)  5 ( 1 ) 49 - 67 2021.10

Research paper (scientific journal), Single Work, Accepted

• Access to Document (DOI)

Japanese Project for Telepsychiatry Evaluation during COVID-19: Treatment Comparison Trial (J-PROTECT): Rationale, design, and methodology

Taishiro Kishimoto, Shotaro Kinoshita, Shogyoku Bun, Yasunori Sato, Momoko Kitazawa, Toshiaki Kikuchi, Mitsuhiro Sado, Akihiro Takamiya, Masaru Mimura, Takashi Nakamae, Yoshinari Abe, Tetsufumi Kanazawa, Yasuo Kawabata, Hiroaki Tomita, Koichi Abe, Akitoyo Hishimoto, Takeshi Asami, Akira Suda, Yoshinori Watanabe, Toru Amagai, Kei Sakuma, Hisashi Kida, Michitaka Funayama, Hiroshi Kimura, Aiko Sato, Shuichiro Fujiwara, Kiichiro Nagao, Naoya Sugiyama, Maki Takamiya, Hideyuki Kodama, Takaharu Azekawa

Contemporary clinical trials (Elsevier)  111   106596 - 106596 2021.10

Research paper (scientific journal), Joint Work, Accepted

　View Summary

INTRODUCTION: The COVID-19 pandemic has had a profound impact on the mental health of people around the world. Anxiety related to infection, stress and stigma caused by the forced changes in daily life have reportedly increased the incidence and symptoms of depression, anxiety disorder and obsessive-compulsive disorder. Under such circumstances, telepsychiatry is gaining importance and attracting a great deal of attention. However, few large pragmatic clinical trials on the use of telepsychiatry targeting multiple psychiatric disorders have been conducted to date. METHODS: The targeted study cohort will consist of adults (>18 years) who meet the DSM-5 diagnostic criteria for either (1) depressive disorders, (2) anxiety disorders, or (3) obsessive-compulsive and related disorders. Patients will be assigned in a 1:1 ratio to either a "telepsychiatry group" (at least 50% of treatments to be conducted using telemedicine, with at least one face-to-face treatment [FTF] within six months) or an "FTF group" (all treatments to be conducted FTF, with no telemedicine). Both groups will receive the usual treatment covered by public medical insurance. The study will utilize a master protocol design in that there will be primary and secondary outcomes for the entire group regardless of diagnosis, as well as the outcomes for each individual disorder group. DISCUSSION: This study will be a non-inferiority trial to test that the treatment effect of telepsychiatry is not inferior to that of FTF alone. This study will provide useful insights into the effect of the COVID-19 pandemic on the practice of psychiatry. TRIAL REGISTRATION: jRCT1030210037, Japan Registry of Clinical Trials (jRCT).

• Access to Document (DOI)

Current status and challenges of the dissemination of telemedicine in Japan after the start of the COVID-19 pandemic

Shotaro Kinoshita, Taishiro Kishimoto

Telemedicine and e-Health (Mary Ann Liebert, Inc.)  (in press) ( 8 ) 1220 - 1224 2021.10

Research paper (scientific journal), Joint Work, Accepted

　View Summary

Online Ahead of Print:December 16, 2021

• Access to Document (DOI)

A Hearing Survey on the Prevalence of Telemedicine : Understanding the Current Situation and Analyzing Issues

木下翔太郎, 成瀨浩史, 吉村健佑, 岸本泰士郎, 榎戸芙佐子, 押淵英弘, 兼子幸一, 瀬戸秀文, 辻本哲士, 長尾喜一郎, 三野進, 村田昌彦, 米田博, 稲垣中

Psychiatria et neurologia Japonica (日本精神神経学会)  124 ( 1 ) 16 - 27 2021.08

Research paper (scientific journal), Joint Work, Accepted

Camptocormia Secondary to Antipsychotic-associated Dystonia of the Rectus Abdominis Muscles Detected by Abdominal Computed Tomography

Yuki Mashima, Hiroyuki Uchida, Shotaro Kinoshita, Yuki Arita, Akira Ninomiya, Masaru Mimura, Takahito Uchida

Journal of Clinical Psychopharmacology (Ovid Technologies (Wolters Kluwer Health))  Publish Ahead of Print ( 5 ) 608 - 610 2021.07

Research paper (scientific journal), Joint Work, Accepted,  ISSN  0271-0749

• Access to Document (DOI)

遠隔医療の普及における信頼の重要性

木下翔太郎

CBEL Report (東京大学生命・医療倫理教育研究センター)  3 ( 2 ) 12 - 13 2021.02

Joint Work, Accepted

Changes in telepsychiatry regulations during the COVID-19 pandemic: 17 countries and regions' approaches to an evolving healthcare landscape

Shotaro Kinoshita, Kelley Cortright, Allison Crawford, Yuya Mizuno, Kazunari Yoshida, Donald Hilty, Daniel Guinart, John Torous, Christoph U. Correll, David J. Castle, Deyvis Rocha, Yuan Yang, Yu-tao Xiang, Pernille Kølbæk, David Dines, Mohammad ElShami, Prakhar Jain, Roy Kallivayalil, Marco Solmi, Angela Favaro, Nicola Veronese, Soraya Seedat, Sangho Shin, Gonzalo Salazar de Pablo, Chun-Hung Chang, Kuan-Pin Su, Hakan Karas, John M. Kane, Peter Yellowlees, Taishiro Kishimoto

Psychological Medicine (Cambridge University Press (CUP))  52 ( 13 ) 1 - 8 2020

Research paper (scientific journal), Joint Work, Accepted,  ISSN  00332917

　View Summary

Published online by Cambridge University Press: 27 November 2020

• Access to Document (DOI)

Tranexamic acid-induced fixed drug eruption confirmed by the drug lymphocyte transformation test.

Kenji Kawaguchi, Shotaro Kinoshita, Motonao Ishikawa, Hiroshi Sakura

Clinical case reports (John Wiley & Sons Ltd.)  7 ( 11 ) 2074 - 2075 2019.11

Research paper (scientific journal), Joint Work, Accepted

　View Summary

We present the first case of multiple fixed drug eruption caused by tranexamic acid, which was confirmed by the LTT. This case was difficult to diagnose because the drug-induced aseptic meningitis by loxoprofen was occurred simultaneously.

• Access to Document (DOI)

ニボルマブ関連大腸炎に対してステロイドが有効であった転移性腎細胞がんの１例

木下翔太郎, 土岐大介, 近藤恒徳

東京女子医科大学雑誌 (東京女子医科大学学会)  89 ( 2 ) 38 - 41 2019.04

Joint Work, Accepted

• Access to Document (DOI)